Who to call at PROCEPT BIOROBOTICS CORPORATION, and when
Fundz watches for the moments PROCEPT BIOROBOTICS CORPORATION starts buying, and tells you who to reach.
- An alert the day PROCEPT BIOROBOTICS CORPORATION raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PROCEPT BIOROBOTICS CORPORATION, from your own LinkedIn network
PROCEPT BIOROBOTICS CORPORATION
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.procept-biorobotics.comAI Executive Summary
AI-powered analysis of 8-K filing content
PROCEPT BioRobotics appointed Dr. Michael Mack, an independent director with cardiac surgery expertise, to its board on October 2, 2026, expanding the board from nine to ten members. This governance enhancement strengthens board expertise and may improve oversight of the medical robotics company.
Key Takeaways
Dr. Michael Mack appointed as Class II independent director, effective immediately, with term expiring at 2029 annual stockholder meeting
Board size increased from nine to ten members, filling a vacancy
2 more takeaways
Related Filings (1)
1 more filing from PROCEPT BIOROBOTICS CORPORATION in the last 90 days
Filing Overview
What This Means
PROCEPT BIOROBOTICS CORPORATION filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.